CME Group
$265.10Change from previous close: +1.19%Absolute change: +$3.12
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $95.32B
- Enterprise value
- $96.92B
- P/E (trailing 12 months)
- 22.5
- Forward P/E
- 20.5
- PEG
- 4.56
- Price/book
- 3.59
- Price/sales
- 14.1
- EV/EBITDA
- 20.3
- EV/revenue
- 14.3
Profitability and growth
- Gross margin
- 100.0%
- Operating margin
- 65.0%
- Net margin
- 63.4%
- ROE
- 15.8%
- ROA
- 1.5%
- Revenue growth (year over year)
- 0.8%
- Earnings growth (year over year)
- 2.5%
Financial health
- Total cash
- $2.28B
- Total debt
- $3.87B
- Debt/equity
- 0.15
- Current ratio
- 1.02
- Quick ratio
- 0.02
Dividends
- Annual dividend per share
- $5.20
- Dividend yield
- 2.0%
- Payout ratio
- 95.4%
- Ex-dividend date
- September 9, 2026
Analysts and estimates
- Average price target
- $283.60
- Median price target
- $285.00
- High price target
- $330.00
- Low price target
- $230.00
- Number of analysts
- 15
- Consensus
- Hold
- Forward EPS
- $12.94
- EPS estimate, current year
- $12.25
Shares and trading
- Beta
- 0.28
- Average volume
- 2.13M
- Shares outstanding
- 359.58M
- Float
- 354.65M
- Institutional ownership
- 91.8%
- Insider ownership
- 0.4%
- Short interest (% of float)
- 1.8%
- Short ratio (days)
- 3.05